Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2010-03-24 16:57:24 UTC |
---|
Update Date | 2023-07-07 20:54:00 UTC |
---|
HMDB ID | HMDB0013466 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Hydroxysphingomyeline C22:1 |
---|
Description | Sphingomyelin (d18:0/22:1(13Z)(OH)) or SM(d18:0/22:1(13Z)(OH)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase. |
---|
Structure | CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CC(O)CCCCCCCCC\C=C/CCCCCCCC InChI=1S/C45H89N2O7P/c1-6-8-10-12-14-16-18-20-21-22-23-25-26-28-30-32-34-36-42(48)40-45(50)46-43(41-54-55(51,52)53-39-38-47(3,4)5)44(49)37-35-33-31-29-27-24-19-17-15-13-11-9-7-2/h20-21,35,37,42-44,48-49H,6-19,22-34,36,38-41H2,1-5H3,(H-,46,50,51,52)/b21-20-,37-35+/t42?,43-,44+/m0/s1 |
---|
Synonyms | Value | Source |
---|
C22:1-OH Sphingomyelin | ChEBI | Hydroxysphingomyeline C22:1 | ChEBI | N-[(13Z)-3-Hydroxydocos-13-enoyl]sphing-4-enine-1-phosphocholine | ChEBI | SM(D18:1/22:1(13Z)(OH)) | ChEBI | N-(15Z-Tetracosenoyl)-sphing-4-enine-1-phosphocholine | HMDB | Sphingomyelin | MetBuilder | N-(3-Hydroxy-13Z-docosenoyl)-1-phosphocholine-sphinganine | MetBuilder | Sphingomyelin(D18:0/22:1(13Z)(OH)) | MetBuilder | N-(3-Hydroxy-13Z-docosenoyl)-1-phosphocholine-dihydrosphingosine | MetBuilder | N-(3-Hydroxy-13Z-docosenoyl)-1-phosphocholine-D-erythro-sphinganine | MetBuilder |
|
---|
Chemical Formula | C45H89N2O7P |
---|
Average Molecular Weight | 801.1711 |
---|
Monoisotopic Molecular Weight | 800.640739724 |
---|
IUPAC Name | (2-{[(2S,3R,4E)-3-hydroxy-2-[(13Z)-3-hydroxydocos-13-enamido]octadec-4-en-1-yl phosphono]oxy}ethyl)trimethylazanium |
---|
Traditional Name | (2-{[(2S,3R,4E)-3-hydroxy-2-[(13Z)-3-hydroxydocos-13-enamido]octadec-4-en-1-yl phosphono]oxy}ethyl)trimethylazanium |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CC(O)CCCCCCCCC\C=C/CCCCCCCC |
---|
InChI Identifier | InChI=1S/C45H89N2O7P/c1-6-8-10-12-14-16-18-20-21-22-23-25-26-28-30-32-34-36-42(48)40-45(50)46-43(41-54-55(51,52)53-39-38-47(3,4)5)44(49)37-35-33-31-29-27-24-19-17-15-13-11-9-7-2/h20-21,35,37,42-44,48-49H,6-19,22-34,36,38-41H2,1-5H3,(H-,46,50,51,52)/b21-20-,37-35+/t42?,43-,44+/m0/s1 |
---|
InChI Key | ZUSFLIGNJFDBRL-FYGIKZFGSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Sphingolipids |
---|
Sub Class | Phosphosphingolipids |
---|
Direct Parent | Phosphosphingolipids |
---|
Alternative Parents | |
---|
Substituents | - Sphingoid-1-phosphate or derivatives
- Phosphocholine
- Phosphoethanolamine
- Dialkyl phosphate
- Fatty amide
- N-acyl-amine
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Fatty acyl
- Alkyl phosphate
- Tetraalkylammonium salt
- Quaternary ammonium salt
- Secondary carboxylic acid amide
- Secondary alcohol
- Carboxamide group
- Carboxylic acid derivative
- Organic zwitterion
- Alcohol
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Amine
- Organic salt
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | Biological locationRoute of exposureSourceEndogenousExogenousFood- Food (HMDB: HMDB0013466)
Animal originMilk and milk productUnfermented milk- Cow milk, pasteurized, vitamin A + D added, 0% fat (FooDB: FOOD00889)
- Cow milk, pasteurized, vitamin A + D added, 1% fat (FooDB: FOOD00890)
- Cow milk, pasteurized, vitamin A + D added, 2% fat (FooDB: FOOD00891)
- Cow milk, pasteurized, vitamin D added, 3.25% fat (FooDB: FOOD00892)
- Exogenous (HMDB: HMDB0013466)
|
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxysphingomyeline C22:1 GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-19 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxysphingomyeline C22:1 GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-19 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxysphingomyeline C22:1 GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-19 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 10V, Positive-QTOF | splash10-0uyr-6011119510-79e6162eb67aba742116 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 20V, Positive-QTOF | splash10-0ue9-2141109100-3e34353068c8d96ce332 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 40V, Positive-QTOF | splash10-001r-9183002200-e1a6e24d5c294cdd8c92 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 10V, Negative-QTOF | splash10-0002-0000001900-f0bf2c437c13cf8e68ba | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 20V, Negative-QTOF | splash10-0002-1035209700-0deda39085c8c9ec0470 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 40V, Negative-QTOF | splash10-0fb9-8129003000-7bf3d790af90956e2030 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 10V, Positive-QTOF | splash10-00di-0000001190-5f59ab3687d9c64fbb8f | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 20V, Positive-QTOF | splash10-00do-0000009290-9d773e68fd4023edc847 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 40V, Positive-QTOF | splash10-0006-0000009110-a60b33cd6179d18b4c5c | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 10V, Negative-QTOF | splash10-0002-0000000900-f54b1b53e53bfc909e12 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 20V, Negative-QTOF | splash10-0002-0001000900-fc8fa6bdcce357041d56 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 40V, Negative-QTOF | splash10-002f-9054100000-89e5eb87436e79efc708 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 10V, Positive-QTOF | splash10-0ue9-0600000090-86b51d73a2259c3b496b | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 20V, Positive-QTOF | splash10-0ue9-0600000090-86b51d73a2259c3b496b | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 40V, Positive-QTOF | splash10-001i-0900000110-b6bf12240587686655a9 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 10V, Positive-QTOF | splash10-0a4i-0000001190-8f77d0ce900f8010316b | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 20V, Positive-QTOF | splash10-0ai0-0000009290-baac0d6a1ddaf3a67d8b | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxysphingomyeline C22:1 40V, Positive-QTOF | splash10-00di-0000009110-f4b4c2a754669cfcd601 | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
Disease References | Pregnancy |
---|
- Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1. [PubMed:24704061 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
| Obesity |
---|
- Cho K, Moon JS, Kang JH, Jang HB, Lee HJ, Park SI, Yu KS, Cho JY: Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12(2):93-101. doi: 10.1111/ijpo.12114. Epub 2016 Feb 22. [PubMed:26910390 ]
- Simone Wahl, Christina Holzapfel, Zhonghao Yu, Michaela Breier, Ivan Kondofersky, Christiane Fuchs, Paula Singmann, Cornelia Prehn, Jerzy Adamski, Harald Grallert, Thomas Illig, Rui Wang-Sattler, Thomas Reinehr (2013). Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children. Metabolomics.
|
|
---|